Notably, several mutations (5× BRCA2, 4× ERBB2, 2× NRAS, 2× HCN1 [hyperpolarization-activated cyclic nucleotide-gated potassium channel 1]) were detected more than once in plasma or stool samples across all patients but never in tumor biopsies. This evidence concerns the gene ERBB2 and neoplasm.